Swire Pacific acquires controlling stake in DeltaHealth

The company signed definitive agreements to increase its stake in March.

Hong Kong-listed international conglomerate, Swire Pacific Limited, has announced the completion of a transaction to increase its stake in DeltaHealth China Limited.

This move follows the company’s initial associate investment in DeltaHealth in 2021 and signed definitive agreements to increase its stake in March.

“We are very excited to be investing further into DeltaHealth and taking a controlling position.” Guy Bradley, Chairman of Swire Pacific, said.

ALSO READ: Hong Kong and Shanghai eye stronger healthcare collaboration

“Demand for high-quality healthcare is growing rapidly as income and living standards rise, and we anticipate demand for the treatment of cardiovascular disease to increase in line with these developments,” Bradley added.

DeltaHealth comprises Shanghai DeltaHealth Hospital focused on cardiovascular care, and an outpatient clinic, DeltaWest Clinic.

Moreover, the group has expanded its services into thoracic surgery and oncology.

Also Read

Gov't opens GBA International Clinical Trial Institute in Shenzhen Park

Hospital Authority and ZOC-SYSU partner to enhance ophthalmology services

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

I want to download the media kit